One hundred years ago the potential for an epileptic seizure to end life was acknowledged. Epileptologists in the nineteenth and early twentieth century described mortality in patients with epilepsy attributable to the epilepsy itselflg. With the advent of effective modern antiepileptic drugs (AEDs), the setting altered. Patients with epilepsy had moved out of asylums into the community and there was less opportunity for direct observation. In an attempt to limit restrictions, risks from epilepsy were minimized then denied; that seizures could not be fatal became 'common knowledge'. The pendulum swung too far. Epilepsy came to be regarded as benign with consequences of seizures underplayed.
That there is an observed overall excess mortality in populations with epilepsy of two to three times that of the general population is not disputed, though this has been largely attributed to mortality from underlying disease6. This is true for patients with recent onset epilepsy. It does not, however, explain the observed excess mortality in patients with chronic epilepsy','. The residual excess, once deaths from underlying disease are excluded, is of relatively small magnitude in unselected community-based cohorts',". Such cohorts are appropriately considered the gold standard in epidemiological research in understanding the natural history of epilepsy. However, given the high remission rates of epilepsy in community based cohorts"*'*, one must question the relevance of mortality data from such studies to patients with long-standing active epilepsy. Mortality rates in the latter are higher and in young adults more than half the deaths are epilepsy related. In two recent studies of patients with chronic largely uncontrolled epilepsy, age-and sex-standardized mortality ratios of 5.1r3 and 15.914 were observed, with 58% and 71% of deaths, respectively, classified as epilepsy related. The second cohort was one of young people with epilepsy and learning difficulty.
In people with epilepsy, deaths may be related to underlying disease or to the epilepsy, or may be unrelated. The distinction is not always clear in individual cases (e.g. suicides, accidents, respiratory deaths). An associated excess, where present, may be demonstrated by comparing the observed incidence of a particular cause of death in a cohort to that in the general population.
Epilepsy-related deaths may be either treatment-or seizure-related. The latter include those in status epilepticus (in the absence of an acute neurological insult where it is the underlying condition rather than status per se that mainly determines mortality15) and deaths in the setting of a single seizure. The second category, hitherto relatively neglected, deserves further discussion. Classification is not without difficulty. Causes of death include trauma or drowning secondary to a seizure. Death may also occur during a habitual seizure in the presence of significant unrelated pathology, such as ischaemic heart disease. The magnitude of such deaths, where there is significant co-existing unrelated pathology, and the relative contribution of the epilepsy to the person's demise is unknown. This area warrants further study in view of the observed second peak in incidence of epilepsy among the elderly and its association with vascular disease. Deaths may also occur from severe aspiration during a seizure or from obstruction due to a food bolus and in such cases post-mortem examination reveals the cause of death. There remains however a category of deaths where persons with epilepsy may die suddenly and 'unexpectedly in the absence of an anatomical or toxicological cause16-*' (SUDEP).
While post-mortem examination is often abnormal with findings of oedema of organs, particularly lungs28, bronchial secretions or minor aspiration, these are not deemed sufficient to cause death. Although occasionally witnessed, the majority of these deaths are unwitnessed, making it difficult to be certain that they occurred during or shortly after a seizure. Where it is sought, circumstantial or physical evidence in favour of a seizure is often foundz9 supporting the view that most cases falling within this category are seizure-related. In some, the body is found face down or the head in such a position that suffocation during postictal insensibility may have contributed to death. In such cases both intrinsic and extrinsic mechanisms are likely to contribute, and classifying individual deaths into either an extrinsic or intrinsic category is not usually possible. In many cases however, probably the majority, there is no obvious extrinsic impediment to respiration.
Mechanisms are not well understood but are probably multifactorial.
Ictal and postictal cardiorespiratory disturbances are likely to be involved in SUDEP cases. Both bradycardia and apnoea, central and/or obstructive, have been reported during seizures, with bradycardia more likely to occur in the presence of apnoea3'. Hypoxia may be aggravated by pulmonary oedema, bronchial secretions and any external obstruction to breathing. It is worth again noting that the majority of these deaths are nocturnal and unwitnessed raising the possibility that unwitnessed seizures are more likely to be fatal. While there may be more than one explanation for this observation, its possible implication to prevention needs to be assessed.
Incidence data on sudden death is broadly consistent with the type of cohort. A community study, based on AED prescribing, observed an incidence of SUDEP of approximately 1: lOOO/yea?'. A study based on identified deaths in a defined community and estimated prevalence of epilepsy reported an incidence of 1 :65332.
Selected populations however have a higher risk. Reports range from 1: 50-100/yea?1*33 among patients in an epilepsy surgery programme, 1:260/year among long-term residents34, 1:200/year in two specialist outpatient cohorts'3*'7, 1:295/year in a cohort of young people with epilepsy and learning difficulty14, and 1:500/year from a further outpatient unit3'. These high incidence rates contrast sharply with only two such deaths among patients in remission in over 5000 patient years reported by the MRC AED Withdrawal Study Group3', and no cases in 3712 person years relating to 564 newlydiagnosed definite cases in the National General Practice Study of Epilepsy'". The latter is a study of incident cases with an increased early mortality from underlying disease and high remission rates in the remainder.
Thus, controlled patients, whether as a result of treatment or inherently less severe disease, have an extremely low risk of sudden death. Cohorts with uncontrolled epilepsy carry a significant risk. This view is supported by a recent finding of higher risk related to number of AEDs ever prescribed, a likely surrogate for poor contro131.
Such sudden unexpected deaths make up between 0" and 50%14 of causes of death in cohorts with epilepsy, although the more usual limits quoted are 7-17%37. Those aged 15-35 have the highest risk, but data on other agegroups is limited. Studies have addressed mortality in the elderly with epilepsf8 and cardiac deaths in populations with epilepsf9. There are difficulties, however, in separating SUDEP deaths from those due to heart disease. Sudden deaths also occur in children40,41 although the incidence is probably lower. Whether this reflects better supervision or differences in seizure severity or both is uncertain. Literature from the U.S.A. highlights Afro-American non-compliant young men who abuse alcohol as particularly at risk23. Such patients are not necessarily representative. Most studies report a higher male incidence. A history of tonic-clonic seizures is usually obtained4*. It has been suggested that sudden deaths are more likely in remote symptomatic epilepsy, but this may reflect more severe epilepsy. The same may apply for the increased risk reported with psychotropic drug prescriptions3'. SUDEP also occurs in primary generalized-epilepsy and in people with relatively few seizures, but as already stated, it is a rare event in remission.
On current evidence, there is no reason to implicate a particular AED in the majority of cases. Differences in reported medication appear to reflect changes over time in prescribing practice. It has been suggested, on the basis of post-mortem AED levels, that withdrawal/noncompliance may be a precipitating factor43*"". The reliability of post-mortem samples has been questionned4' and the significance of absolute values of drug levels, once overdose is excluded, is uncertain. Nevertheless, the potential contribution of improved control in reducing risk of sudden death, and the dangers inherent in noncompliance and precipitous drug withdrawal cannot be dismissed. The significance of excessive alcohol, sleep deprivation or medication withdrawal probably lies in their potential to precipitate seizures. There is also the theoretical possibility that they may, in addition, predispose to autonomic instability thus increasing the risk of death in a seizure.
There is no uniformity in death certification of SUDEP cases, although, given that over 90% of identified cases in our experience in the U.K.46 are referred to the coroner and undergo postmortem examination, uniformity is possible and must be sought. Status epilepticus, though unsubstantiated, is often recorded as a cause of death, although our impression is that this is less likely to be the case now than previously. Unfortunately, with the situation as it stands and until there are agreements regarding definitions and guidelines for certification of epilepsy related deaths, and for the methods by which data is subsequently incorporated into national mortality figures, the exact numbers involved remain unknown. It is estimated that 400 individuals with epilepsy per year die a sudden unexpected death. This figure excludes other epilepsy-related deaths. A workshop, curently being planned, addressing these issues as well as directions for future research is long overdue.
Nevertheless, while much remains to be done, there has been increased awareness of epilepsyrelated deaths including sudden unexpected deaths over the last few years. Much of the impetus has come from the self-help group Epilepsy Bereaved?47, and through its efforts some of the understandable reluctance of all concerned to address the small but definite risk to life that epilepsy carries, particularly generalized uncontrolled seizures, has been erased. Acknowledgement without overstatement, rather than attempts at concealment, is required to place this risk in perspective. This would allow the physician to take sudden deaths into consideration in clinical management, and the patient to make more informed decisions when contemplating treatment options and when making choices 237 regarding social circumstances. It also allows us, perhaps belatedly, to add preservation of life to other aims in the treatment of epilepsy.
